When genetic engineering is the environmentally friendly choice – Genetic Literacy Project

Thisarticleoriginally appeared at Ensia and has been republished here with permission.

Which is more disruptive to a plant: genetic engineering or conventional breeding?

It often surprises people to learn that GE commonly causes less disruption to plants than conventional techniques of breeding. But equally profound is the realization that the latest GE techniques, coupled with a rapidly expanding ability to analyze massive amounts of genetic material, allow us to make super-modest changes in crop plant genes that will enable farmers to produce more food with fewer adverse environmental impacts. Such super-modest changes are possible with CRISPR-based genome editing, a powerful set of new genetic tools that is leading a revolution in biology.

My interest in GE crops stems from my desire to provide more effective and sustainable plant disease control for farmers worldwide. Diseases often destroy 10 to 15 percent of potential crop production, resulting in global losses of billions of dollars annually. The risk of disease-related losses provides an incentive to farmers to use disease-control products such as pesticides. One of my strongest areas of expertise is in the use of pesticides for disease control. Pesticides certainly can be useful in farming systems worldwide, but they have significant downsides from a sustainability perspective. Used improperly, they can contaminate foods. They can pose a risk to farm workers. And they must be manufactured, shipped and applied all processes with a measurable environmental footprint. Therefore, I am always seeking to reduce pesticide use by offering farmers more sustainable approaches to disease management.

What follows are examples of how minimal GE changes can be applied to make farming more environmentally friendly by protecting crops from disease. They represent just a small sampling of the broad landscape of opportunities for enhancing food security and agricultural sustainability that innovations in molecular biology offer today.

Genetically altering crops the way these examples demonstrate creates no cause for concern for plants or people. Mutations occur naturally every time a plant makes a seed; in fact, they are the very foundation of evolution. All of the food we eat has all kinds of mutations, and eating plants with mutations does not cause mutations in us.

Knocking Out Susceptibility

A striking example of how a tiny genetic change can make a big difference to plant health is the strategy of knocking out a plant gene that microorganisms can benefit from. Invading microorganisms sometimes hijack certain plant molecules to help themselves infect the plant. A gene that produces such a plant molecule is known as a susceptibility gene.

We can use CRISPR-based genome editing to create a targeted mutation in a susceptibility gene. A change of as little as a single nucleotide in the plants genetic material the smallest genetic change possible can confer disease resistance in a way that is absolutely indistinguishable from natural mutations that can happen spontaneously. Yet if the target gene and mutation site are carefully selected, a one-nucleotide mutation may be enough to achieve an important outcome.

There is a substantial body of research showing proof-of-concept that a knockout of a susceptibility gene can increase resistance in plants to a very wide variety of disease-causing microorganisms. An example that caught my attention pertained to powdery mildew of wheat, because fungicides (pesticides that control fungi) are commonly used against this disease. While this particular genetic knockout is not yet commercialized, I personally would rather eat wheat products from varieties that control disease through genetics than from crops treated with fungicides.

The Power of Viral Snippets

Plant viruses are often difficult to control in susceptible crop varieties. Conventional breeding can help make plants resistant to viruses, but sometimes it is not successful.

Early approaches to engineering virus resistance in plants involved inserting a gene from the virus into the plants genetic material. For example, plant-infecting viruses are surrounded by a protective layer of protein, called the coat protein. The gene for the coat protein of a virus called papaya ring spot virus was inserted into papaya. Through a process called RNAi, this empowers the plant to inactivate the virus when it invades. GE papaya has been a spectacular success, in large part saving the Hawaiian papaya industry.

Through time, researchers discovered that even just a very small fragment from one viral gene can stimulate RNAi-based resistance if precisely placed within a specific location in the plants DNA. Even better, they found we can stack resistance genes engineered with extremely modest changes in order to create a plant highly resistant to multiple viruses. This is important because, in the field, crops are often exposed to infection by several viruses.

Does eating this tiny bit of a viral gene sequence concern me? Absolutely not, for many reasons, including:

Tweaking Sentry Molecules

Microorganisms can often overcome plants biochemical defenses by producing molecules called effectors that interfere with those defenses. Plants respond by evolving proteins to recognize and disable these effector molecules. These recognition proteins are called R proteins (R standing for resistance). Their job is to recognize the invading effector molecule and trigger additional defenses. A third interesting approach, then, to help plants resist an invading microorganism is to engineer an R protein so that it recognizes effector molecules other than the one it evolved to detect. We can then use CRISPR to supply a plant with the very small amount of DNA needed to empower it to make this protein.

This approach, like susceptibility knockouts, is quite feasible, based on published research. Commercial implementation will require some willing private- or public-sector entity to do the development work and to face the very substantial and costly challenges of the regulatory process.

Engineered for Sustainability

The three examples here show that extremely modest engineered changes in plant genetics can result in very important benefits. All three examples involve engineered changes that trigger the natural defenses of the plant. No novel defense mechanisms were introduced in these research projects, a fact that may appeal to some consumers. The wise use of the advanced GE methods illustrated here, as well as others described elsewhere, has the potential to increase the sustainability of our food production systems, particularly given the well-established safety of GE crops and their products for consumption.

Read more here:
When genetic engineering is the environmentally friendly choice - Genetic Literacy Project

Scientists Reprogram Cells’ DNA Using Nanotechnology – Voice of America

Researchers have turned skin cells into blood vessel tissue to save a mouse's wounded leg. They were able to do that simply by tapping the wound with a chip that uses nanotechnology to inject new DNA into the cells.

This step follows a number of significant advances in techniques to turn one type of cell into another. Scientists hope this so-called cell reprogramming can one day be used to regenerate damaged tissue, or cure conditions such as Parkinson's disease.

The research, published Monday in Nature Nanotechnology, combines existing biotechnology and nanotechnology to create a new technique called tissue nano-transfection. The researchers turned skin cells into brain cells, in addition to demonstrating the therapeutic benefit of turning them into vascular cells.

Maintaining blood flow to deliver nutrients around a wound is critical for recovery, so by making more blood vessel cells, researchers found that a mouse's wounded limb was more likely to survive.

A brief electric current causes the chip to eject DNA fragments that reprogram the cells. The particles only enter the very top layer of cells, so L. James Lee, a biomolecular engineer at Ohio State University and study co-author, said he was surprised to find reprogrammed cells deep within the tissue.

"Within 24 hours after the transfection, we actually observed the propagation of the biological functions deep inside the skin," Lee told VOA. "So we were very surprised that it actually works for tissue." Lee said it wasn't yet entirely clear why this was possible.

Masato Nakafuku, who studies cell reprogramming at the University of Cincinnati and was not associated with the research, told VOA that he, too, was surprised "to see very efficient generation of the [vascular] cells."

Nakafuku added a cautionary note: It is not clear that that tissue nano-transfection will work on animals as large as humans, since the treatment would have to reprogram cells much deeper in the tissue in order to be effective.

Lee told VOA he is hopeful that upcoming human trials will prove the real-world effectiveness of tissue nano-transfection.

In theory, tissue nano-transfection should be able to turn any cell in the body into any other cell type. That could make therapeutic applications of cell reprogramming easier and safer, because cells would stay in the body during reprogramming. If cells are removed from the body, reprogrammed and then returned, they could be attacked by the immune system.

Original post:
Scientists Reprogram Cells' DNA Using Nanotechnology - Voice of America

Under The Microscope: UTC Honors College Student Working On Nanotechnology In Japan – The Chattanoogan

Mesenchymal stem cells.Cooper Thome is working with mesenchymal stem cells.What the heck are mesenchymal stem cells?

In regular folks terms, theyre stem cells that can grow into a variety of different cells, from bone to cartilage, from muscle to fat.

They have many therapeutic applications, from the treatment of orthopedic injuries to autoimmune diseases, Mr. Thome says. Knowing how various environments and factors affect stem cells is very important if we wish to make further advancements in the types and viability of stem-cell treatments.

Mr. Thome is a UTC Honors College student whos in Japan this summer, working an internship in nanotechnology at the National Institute of Materials Science in the city of Tsukuba. A chemical engineering major in the College of Engineering and Computer Science, he has three semesters left before graduation.

Landing the Japanese internship is a major accomplishment, and Mr. Thome is one of only six students from across the U.S., from Florida to California, who were chosen. Hell be in Japan until early August.

After hes finished with the internship in Japan, hell fly into Atlanta to attend a research convocation for the various National Nanotechnology Coordinated Infrastructure REU participants from universities in the U.S, he says.

Translation: A national conference on real-world applications for nanotechnology. REU stands for Research Experiences for Undergraduates, so its geared to college students.

In addition to the terrific research hes been pursuing in that field including an important internship last summer at Georgia Techs Institute for Electronics and Nanotechnology and now this International REU in Japan hes been an active and valued member of the Brock Scholars community in the Honors College, helping to mentor new students during our orientation retreats, leading nature hikes, and more, says Dr. Gregory ODea, associate dean of the Honors College.

Back in Japan, Mr. Thome takes tiny, tiny stem cells usually about one millionth of a meter in size and grows them for tissue engineering.

The fabrication and characterization of the patterns is an important part of the project. It has been shown that the actual patterns in which you grow the cells can influence their behavior greatly, so I am going to explore some of the implications of that.

What he learned at UTC has been critical to his success outside of the school, he says, including both the Japan internship and the one at Georgia Tech.

Im really thankful for the Honors College, as well as the faculty and staff of the CECS for all the help theyve given to me up to this point, he says. Ive been lucky enough to be around people and in an environment that has pushed me to pursue some really cool (and educational and professional) experiences and positions.

As for the difference between the societies in the U.S. and Japan, Mr. Thome understates that its quite different and, especially since I dont speak Japanese, it can be confusing at times.

In general, everyone here is extremely kind and helpful, though. Theres definitely a type of social structure and formality that isnt really prevalent in the United States.

Ive met a lot of people from all over the world here, too. Tsukuba is a science city with a high population of foreign researchers, and its really interesting to talk to people about various cultural differences.

View original post here:
Under The Microscope: UTC Honors College Student Working On Nanotechnology In Japan - The Chattanoogan

Nanotechnology Used in Self-Healing Batteries – ENGINEERING.com

Forget about building a better mousetrap; make a better battery and you expand the possibilities for renewable energy and cleaner vehicles. Let's see what's happening on the front lines of battery research.

Li-ion is becoming the standard technology for rechargeable batteries, but it's not devoid of shortcomings. These batteries often employ a carbon-based negative electrode. Silicon electrodes would provide a higher energy density (energy per unit of volume), making them more desirable for electric vehicles. The problem is that silicon expands and contracts with recharge cycles, eventually causing the electrode to fall apart, kind of like freezing and thawing of a road surface creates potholes.

Engineers at the University of Illinois are taking a multifaceted approach to this problem. One potential solution is a self-healing electrode that uses a conductive substance embedded into microcapsules. As the electrodes expand, the microcapsules rupture and disperse the crack-filling material.

Microcapsules rupture and fill cracks with a conductive material. (Image: University of Illinois)

The same U of I team is working on a self-healing electrode that features dynamic bonding between the silicon nanoparticles and a polymer binder. Early tests have shown that silicon electrodes employing this technology remain stable through several hundred charging cycles.

One problem that plagues Li-ion batteries is the formation of dendrites - tiny metallic structures that form on one electrode and grow toward the other, causing the battery to eventually short-circuit and possibly catch fire The dendrites easily grow in the liquid electrolyte that's prevalent in Li-ion technology, so researchers developed solid electrolytes, which are stronger. But as any programmer will tell you, when you fix one bug you often create another. As the battery goes through charging/discharging cycles, the electrodes expand and contract, which can damage the solid electrolyte and allow dendrites to form.

Scientists at MIT have examined the cause of dendrite formation and found that previous researchers were focusing on the wrong problem. They determined that it's not the weakness of the electrolyte material that allows dendrites to form, it's the uneven surface.

Smooth electrolyte surfaces can prevent dendrite formation. (Image: MIT)

Rough surfaces provide places where dendrites can infiltrate the material, eventually working their way to through to the other side. Engineers have been working on stronger electrolyte materials under the assumption that dendrites will form no matter what, so they need a tougher "wall" to block them. MIT's research shows that with ultra-smooth solid electrolyte surfaces, dendrites can be prevented rather than blocked. Now the question is whether these electrolytes can be manufactured at a reasonable cost. If so, it could open the possibilities for solid-state Li-ion batteries to be used in electric vehicles and renewable energy systems.

It's been more than two centuries since Alessandro Volta invented the "voltaic pile" - the first battery in the modern sense of the word. Since then, chemists, materials scientists, and engineers have tweaked the device's molecules in order to improve performance. Those enhancements will keep the inventor's name on our lips for many years to come, as we see more electric vehicles like the Volt and renewable energy from photovoltaics, both of which store energy in Volta's electrochemical sandwich. Saluti, Alessandro!

_______________________________________________________________

Excerpt from:
Nanotechnology Used in Self-Healing Batteries - ENGINEERING.com

Ohio State researchers develop regenerative medicine breakthrough – The Ohio State University News (press release)

Researcher Chandan Sen with the nanotechnology-based chip designed to deliver biological "cargo" for cell conversion. Image: The Ohio State University Wexner Medical Center

*** Video and photos available for download: http://bit.ly/2tyoPdM ***

COLUMBUS, Ohio Researchers at The Ohio State University Wexner Medical Center and Ohio States College of Engineering have developed a new technology, Tissue Nanotransfection (TNT), that can generate any cell type of interest for treatment within the patients own body. This technology may be used to repair injured tissue or restore function of aging tissue, including organs, blood vessels and nerve cells.

Results of the regenerative medicine study published today in the journalNatureNanotechnology.

By using our novel nanochip technology, injured or compromised organs can be replaced. We have shown that skin is a fertile land where we can grow the elements of any organ that is declining, said Dr. Chandan Sen, director of Ohio States Center for Regenerative Medicine & Cell Based Therapies, who co-led the study with L. James Lee, professor of chemical and biomolecular engineering with Ohio States College of Engineering in collaboration with Ohio States Nanoscale Science and Engineering Center.

Researchers studied mice and pigs in these experiments. In the study, researchers were able to reprogram skin cells to become vascular cells in badly injured legs that lacked blood flow. Within one week, active blood vessels appeared in the injured leg, and by the second week, the leg was saved. In lab tests, this technology was also shown to reprogram skin cells in the live body into nerve cells that were injected into brain-injured mice to help them recover from stroke.

This is difficult to imagine, but it is achievable, successfully working about 98 percent of the time. With this technology, we can convert skin cells into elements of any organ with just one touch. This process only takes less than a second and is non-invasive, and then you're off. The chip does not stay with you, and the reprogramming of the cell starts. Our technology keeps the cells in the body under immune surveillance, so immune suppression is not necessary, said Sen, who also is executive director of Ohio States Comprehensive Wound Center.

TNT technology has two major components: First is a nanotechnology-based chip designed to deliver cargo to adult cells in the live body. Second is the design of specific biological cargo for cell conversion. This cargo, when delivered using the chip, converts an adult cell from one type to another, said first author Daniel Gallego-Perez, an assistant professor of biomedical engineering and general surgery who also was a postdoctoral researcher in both Sens and Lees laboratories.

TNT doesnt require any laboratory-based procedures and may be implemented at the point of care. The procedure is also non-invasive. The cargo is delivered by zapping the device with a small electrical charge thats barely felt by the patient.

The concept is very simple, Lee said. As a matter of fact, we were even surprised how it worked so well. In my lab, we have ongoing research trying to understand the mechanism and do even better. So, this is the beginning, more to come.

Researchers plan to start clinical trials next year to test this technology in humans, Sen said.

Funding for this research was provided by Ohio States Center for Regenerative Medicine and Cell-Based Therapies, Ohio States Nanoscale Science and Engineering Center and Leslie and Abigail Wexner.

Read more:
Ohio State researchers develop regenerative medicine breakthrough - The Ohio State University News (press release)

PGA Championship 2017: Jordan Spieth chases golf immortality – GolfDigest.com

At the 99th PGA Championship, Jordan Spieth for the first time will be playing for one of the transcendentprizes in golf: the career Grand Slam. Of course, the 24-year-old is quick to deny hes thinking that way. Spieth insists his focus will be on simply winning the PGA, which, since his victory last month at the Open Championship, is now the only one of the four professional majors he hasnt won. I mean this, he intoned last week at Firestone in explaining his mindset. Its just a major.

Then again, Spieth, who because of his back-nine heroics at Royal Birkdale is occupying the same kind of attention in the golf public consciousness as he did when he won the first two majors in 2015, is floating on a cloud of confidence and well being. Free rolling, as his caddie, Michael Greller puts it. Its the approximate state that three of the five greats who achieved the career Grand Slam were in the year they captured the final leg, given that Ben Hogan in 1953 and Tiger Woods in 2000 each won three major championships, while in 1966 Jack Nicklaus won two.

So while Spieth may insist that because he expects to play in 30 future PGAs, if he doesnt win at Quail Hollow, its not going to be a big-time bummer whatsoever because I know I have plenty of opportunities, theres a chance he may never have a freer roll. And for the record, the last three winners of the Grand SlamGary Player, Nicklaus and Woodsall completed the feat in their 20s. For that matter, golfs first Grand Slammer, Gene Sarazen, won his first two majors at age 20, sooner even than Spieth. In the journey to the career Grand Slam, the time to take advantage of a head start is always now.

If all this sounds a bit over-caffeinated, its because career Grand Slams in golf are special. They are more rare than in tennis, where eight men (the latest Novak Djokavic) have done it. But more importantly, it can besad to see great players fall one major short. Counting Spieth, 12 players have achieved three legs without getting the fourth. And those for whom valiant attempts at the final have been thwarted by bad luck or multiplying tension or bothespecially Sam Snead with the U.S. Open, and Arnold Palmer and Tom Watson with the PGAhave ended up on a slightly lower tier of the pantheon. It looks like that has happened to Phil Mickelson in his quest for a U.S. Open, and that there is an increasing possibility of this happening to Rory McIlroy at Augusta National.

RELATED: Golf Digest PodcastSpieth's pursuit of the career Grand Slam compared to Tiger

Not that the career Grand Slam is a perfect measure of greatness. Walter Hagen, who won 11 major championships, didnt have a real shot at what evolved into the Grand Slam because the Masters wasnt even played until he was well past his prime. And what of Bobby Jones original Grand Slam in 1930, winning the U.S. Open and Amateur and their British counterparts in one year, which has never been replicated by any golfer over an entire career? That feat, or the still unattained the calendar professional Grand Slam, or even the Tiger Slam of 2000-01, would all have to be more exalted than the career Grand Slam.

In the journey to the career Grand Slam, the time to take advantage ofa head start is always now.

Still, other than those one-offs, theres a good argument that theres no marker in golf better at historically differentiating the best from the rest than the career Grand Slam. It requires some special things. Theres the tennis analogy of the complete game in four different conditions especially the Masters, U.S. Open and British Open. (The PGA might be the favorite set up of the tour pros because its still U.S. Open light).

Then theres overcoming the pressure of finally capturing the last leg, which builds the more years that go by. Even Spieth was attuned to this challenge, conceding that he would have to be careful not to make the PGA an obsession. The con, he said of being just one major away from the career Grand Slam, and what makes it more difficult than just saying its another major, is that its one a year now instead of four a year that that focuses on, if thats what the focus is.

Clearly, getting the final leg is a validator. It means meeting the moment, demonstrating the rare ability to bring out your best golf when it means the most, when the pressure is highest, when the battle is hardest. It takes greatness.

That said, not all career Grand Slams were created equal. Heres how I would rank them, counting down from least to most significant:

5. Gene SarazenThough he will always be a giant figure with seven major championships, Sarazen is golfs greatest beneficiary of retroactive history. Not only did he win the 1935 Masters by getting into a playoff on the wings of holing a 4-wood from 235 yards on the 15th hole on Sunday, but the Masters was far from being considered a major championship, probably not reaching that status until Ben Hogan and Snead played off in 1954. There was no pressure on Sarazen because he didnt even know he was making history.

RELATED: Spieth not finding any negatives in career Grand Slam bid

4. Gary PlayerIndisputably the games greatest international golfer, with nine majors included among his 159 victories worldwide, Player was ruthlessly efficient in clicking off the four majors in six-year period that ended with his victory at the 1965 U.S. Open at Bellerive, in the only time he would win that championship. Its quite possible that no one ever wanted the achievement more. I was aware of the Grand Slam in 1953 because Hogan was my hero in golf, Player said by phone last week, and I knew when he won at Carnoustie he had the four.

The prize was in his head when he won his first major at the 1959 Open Championship, and soon he became determined to beat rivals Arnold Palmer and Jack Nicklaus to the mark. Though he hadnt won a major since the 1962 PGA, he was primed at Bellerive. I was squatting with 325 pounds, the fittest I ever was in my life, Player said. He was going to a church in St. Louis every day and praying for courage. He wore the same black shirt every day, washing in the sink of his hotel room each night. When he got to the course, he devoted a few minutes to standing before the scoreboard, which had past winners names, and envisioned his own. I saw Gary Player, winner, 1965, and Gary Player winner of the Grand Slam, he said. I dont know if any golfer ever, ever, was as focused as I was that week on winning.

And if Player had lost the playoff to Kel Nagel, does he think he might have suffered the same frustrating fate in the U.S. Open as Snead? Oh, no. I would have won it, absolutely no doubt, he said. Of such minds are career Grand Slam winners made.

3. Jack NicklausThe man who would go on to win the equivalent of three career Grand Slams achieved his first one as a forgone conclusion, he was clearly so good. But even Nicklaus confesses an early setback in 1963 at Lytham, where he bogeyed the final two holes to lose by one, created a crisis of confidence in his ability to win the Open Championship. With three legs of the Slam completed, he finished second at St. Andrews in 1964, and still wondered if his high ball flight would always hold him back on the windy linksland.

He seemed to find the key at Muirfield in 1966, but with a three-stroke lead with seven to play, he three-putted from seven feet, missing a 15-inch putt. I experienced one of the most severe mental jolts Ive ever suffered on a golf course, Nicklaus confessed in his autobiography. Jittery is not a strong enough word to describe my feelings. He bogeyed two of the next three holes, but then, as Spieth did at Birkdale, found a way at the 11th hour to go from negative to positive and eeked out a one-stroke win.

Realizing he had won the Slam, Nicklaus was overcome at the trophy presentation. He wrote: Being about to receive something that even I, never much of a self-doubter, had genuinely doubted would ever be mine, was extremely emotional. From that point, the Open Championship became the major where Nicklaus most consistently contended.

2. Ben HoganTrue, the professional Grand Slam hadnt yet become a thing when Hogan won his fourth leg at Carnoustie in 1953 at age 40. In fact, Hogan, who hadnt won the first of his nine majors until he was 34, wasnt thinking career Grand Slam when he made his first trip to the Open Championship. He had gone because friends had urged him to for the good of the game, and for the challenge. Once there, he became engaged with a monastic purpose that entranced the Scots, keeping legs battered by his car accident functioning through long, soaking baths, mastering the nuances of the small British ball and stoically executing with near perfection. His victory remains perhaps golfs supreme example of a one-shot, do-or-die, all-or-nothing, surgical strike that culminated in a glorious mission accomplished. It earned Hogan a ticker-tape parade when he returned to the U.S., and turned out to be his final major-championship victory.

1. Tiger WoodsUntil further notice, his is the most brilliantly dominating career Grand Slam. Its Himalayan peaks remain prominent on golfs landscape: the 1997 Masters (by 12 strokes), the 2000 U.S. Open (by 15 strokes) and the 2000 Open Championship (by eight strokes). But it was the 1999 PGA at Medinah where Woods seemingly inevitable ascendance could have been stalled, and the tricky, seven-foot, left-to-right par putt he made on the 71st hole to maintain a one-stroke lead over Sergio Garcia may go down as the most important putt of Woods career. Any pain Woods suffered in his few close loses in majors for the first 12 years of his career was negligible, but losing at Medinah probably would have left a mark. With appropriate theater, Woods closed out his first Grand Slam with a triumphant march up the 18th at St. Andrews.

If Spieth can claim a fourth leg at Quail Hollow, where would his Grand Slam rank? Third best, behind Woods and Hogan.

Spieth, as the sixth holder, would be the youngest, by eight months. Hes been more stalwart than opportunist, having led or been tied for the lead in 15 of the 70 major championship rounds he has played. But other than his first major win, a wire-to wire job at the 2015 Masters, Spieths victories have been tight ones in which, for all his magic with the short game and putter, his tee-to-green play has lacked the majesty of Woods or Nicklaus or Hogan. Hes also lost the lead late at two Masters, leaving more scar tissue at an early age than Woods, Nicklaus or Player experienced.

Then again, Spieths combination of passionate competitiveness and personal charm is reminiscent of Jones, and engenders a similar degree of public devotion. If he could close out the Slam in Charlotte, his resultant popularity would lift golf and his persona into Jones/Palmer/Woods territory.

It would also install him firmly on the games throne at an early age. Nicklaus and especially Woods showed such a position can be a self-perpetuating mental edge. As good as being No. 1 in the world is, its betterthrough an early career Grand Slamto have proved youre the best when it matters most.

RELATED: The history of Grand Slam pursuits

WATCH: GOLF DIGEST VIDEOS

Jordan Spieth's epic claret jug celebration

Continue reading here:
PGA Championship 2017: Jordan Spieth chases golf immortality - GolfDigest.com

How to live forever: Every single way you can achieve immortality – GQ India

Ten years ago, you couldve been forgiven for expecting a satire of silicon valley fantasies when you clicked on that header. But its 2017 and things have changed. We no longer balk at the idea of fighting death, or dismiss it as an esoteric pursuit. Nearly 66 years after the Welsh bard Dylan Thomas famously implored: Do not go gentle into that good night, scientists are finally saying, do not go at all!. But theres only so much that hope and promise of future can do, and many still take sciences grand plans for human immortality with a pinch of salt. While it may be true that scientific efforts towards defeating death or even delaying it are yet to come anywhere close to fruition, there has never before been more promise in ageing research than now.Before we get to how (or whether at all) defeat ageing and live forever, we need to ponder a little on a question historically dismissed as an inevitability:

Weve known for quite sometime the answer to the first question we die because we age. And we age for the same reason an everyday appliance like your TV or smartphone does wear and tear. As to the question of whether we have to die well, as far as nature is concerned, we dont really die at all! Its understandable if that sounds a little cryptic. However, while we mull mostly upon our individual lives, science since the time of Darwin is in agreement that nature looks at humanity as a species wherein we feature merely as a conduit for information to be passed on through procreation. A prime reason for ageing, scientists have argued is the focus in human biology on reproduction and the amount of resources our body demarcates for procreation instead of regeneration. In the face of advancements in science, reproduction no longer needs such massive resources leading some scientists to the conclusion that death isnt a natural inevitability, but rather a surmountable challenge.

Health and medication:

Pursuit of immortality or escape from death has historically revolved around some kind magical/mythical element or herb or elixir that when consumed will grant immortality. Indian mythology prominently features the eternal amrutor nectar, while western esotericism has obsessed for centuries over the alchemic myth of the philosophers stone and elixir of life. But is it conceivable in 2017 that simply popping a pill or taking a sip of some concoction could cure death? Sure it is, just ask Centre for Ageing Researchs Dr Nir Barzilai, who has spent over three decades researching a single well known diabetes medication that he thinks is the cure for ageing. In fact, while Barzilais research aims at stalling ageing and depletion of youth rather than longevity, it has already found many takers in the scientific community. The fairly common pill called Metformin, which sells for a surprisingly cheap 3 a pop is subject of much controversy, but it is also the subject of one of the best known ongoing researches in the field of ageing.

Genetics and chromosomes:

At a cellular level, scientists have long argued that ageing takes place because of a certain chromosomal constituent known as telomeres. As cells undergo division, the telomeres present at the edge of chromosomes consistently start eroding and subsequently lead to cell death. Whereas our bodies have the inherent capacity to sustain our cells for much longer, telomeres act as a self-imposed kill-switch to fight tumour-formation. But just as any switch, it comes with it the possibility of being reversed. While telomeres-based research has been in focus for quite some time, science has in recent years witnessed several breakthroughs that are more than just promising. Just this week, in a research conducted by US-based Houston Methodist Research Institute that was published in the Journal of the American College of Cardiology, scientists have concluded that reversing telomere-erosion can slow down or tackle a number of problems associated with ageing specifically diseases such as progeria, which causes increased ageing in children.

SENS and Silicon Valleys quest for immortality:

So youve made your billions, and then some. But no matter the depth of your coffers, there comes a point at which even abject profligacy wouldnt exhaust your wealth before you run out of time to spend it. This is the daunting challenge facing the likes of Googles Sergey Brin and Larry Page and Facebooks Mark Zuckerberg. And one that theyre keen on taking head-on through the Silicon Valley-funded research effort SENS or Strategies for Engineered Negligible Senescence. While research done at SENS hasnt made much news in recent years, the fact remains that it is one of the most well-funded efforts for defeating ageing.

Merging man and machine:

Talk sci-tech today and it becomes almost impossible to leave out Silicon Valley trailblazer Elon Musk and his projects. While universities around the world are researching ways using machines to enhance our lives, Musk is going a step further by trying to put a machine directly in out brains through his project Neuralink. Unlike his flagship Tesla or SpaceX, Musks Neuralink has been kept largely away from the public eye save for a hints through his Twitter feed. Musk himself has confessed that his aim for the company is to achieve Neuralace a primary linkage between our minds and computers to enhance our memory and cognitive capabilities. But while this might seem more rooted in AI than in ageing research, it constitutes what many feel is the first step towards the kind of man-machine interface that weve seen in countless pop-culture references such as Black Mirrors highly rated episode San Junipero or Johnny Depps vastly underrated sci-fi flick transcendence where our consciousness exists without even a body as a computer program.

But regardless of how we achieve it, or whether we achieve it at all, it is a testament to sheer human optimism that we now aim to outlive our own modern, scientific civilisation, which from its dawn in the industrial revolution barely circumscribes four centuries. The goal, it would seem, isnt as forever as forever goes but rather juststretch it until it breaks (and keep hoping it doesnt).

NOW READ

Theres now a pill that can extend your life

How to live, according to centenarians

> More on Get Smart

Go here to read the rest:
How to live forever: Every single way you can achieve immortality - GQ India

Immortality calling: Who’ll be next Dolphins, Heat, Marlins or Panthers star in Hall of Fame? – Miami Herald (blog)

Dolphins great Jason Taylor on Saturday became the 26th man immortalized as a Hall of Famer after having worn the uniform of, or coached, the Miami Dolphins, Heat, Marlins or Panthers. Taylor sailed in with the fifth-greatest percentage of his career spent in South Florida. The Hall of Miami club would be much more exclusive, but it includes even those who spent only a very small portion of their careers wearing a local teams uniform.

The question for today:

Whos next?

Many former players for Miamis Big Four pro teams will join that list now at 26 upon their retirement, of course. But what about current Dolphins, Marlins, Heat or Panthers?

Well tackle both categories and provide our Top 10 in each of the likeliest future Hall of Famers formerly or currently cheered by local fans. First, though, a complete list of those 26 men now enshrined, listed in order of the percentage of games played (or in two cases coached) in South Florida. Games include playoffs, and the four team leaders names are capitalized and underlined:

DAN MARINO, Dolphins, 100.00 percent, 260 of 260, 1983-99; Bob Griese, Dolphins, 100.00, 173 of 173, 1967-80; Dwight Stephenson, Dolphins, 100.00, 125 of 125, 1980-87; Larry Little, Dolphins, 87.69, 171 of 195, 1969-80; Jason Taylor, Dolphins, 86.78, 210 of 242, 1997-07, 09, 11; Jim Langer, Dolphins, 85.89, 140 of 163, 1970-79; Coach Don Shula, Dolphins, 80.42, 423 of 526, 1970-95; Larry Csonka, Dolphins, 74.68, 118 of 158, 1968-74, 79; ALONZO MOURNING, Heat, 72.35, 675 of 933, 1995-02, 04-08; Nick Buoniconti, Dolphins, 52.55, 103 of 196, 1969-76; Coach Pat Riley, Heat, 42.04, 919 of 2,186, 1995-03, 05-08; Paul Warfield, Dolphins, 40.57, 71 of 175, 1970-74; PAVEL BURE, Panthers, 29.63, 227 of 766, 1998-02; Shaquille ONeal, Heat, 17.22, 245 of 1,423, 2004-08; Gary Payton, Heat, 11.69, 174 of 1,489, 2005-07; Junior Seau, Dolphins, 10.79, 30 of 278, 2003-05; PUDGE RODRIGUEZ, Marlins, 6.23, 161 of 2,583, 2003; Joe Nieuwendyk, Panthers, 5.65, 80 of 1,415, 2005-07; Ed Belfour, Panthers, 5.16, 58 of 1,124, 2006-07; Andre Dawson, Marlins, 4.58, 121 of 2,642, 1995-96; Thurman Thomas, Dolphins, 4.43, 9 of 203, 2000; Tim Raines, Marlins, 3.86, 98 of 2,536, 2002; Dino Ciccarelli, Panthers, 3.06, 42 of 1,373, 1997-99; Igor Larionov, Panthers, 2.43, 26 of 1,071, 2000-01; Cris Carter, Dolphins, 2.02, 5 of 248, 2002; Mike Piazza, Marlins, 0.26, 5 of 1,944, 1998.

Now, the players we once had who are the most likely to be headed for their sports highest honor, led by the Heats erstwhile Big 3, by the Panthers recently departed ageless wonder, and by the subject of perhaps the worst trade in Marlins history:

1. LeBron James (29.6 percent of games played were for Heat) Our Hall odds: 100 percent. But only because the percents dont go any higher.

2. Jaromir Jagr (9.7 percent for Panthers) Hall odds: 100 percent. Every bit the certainty LeBron is as NHLs No.3 all-time goal scorer.

3. Miguel Cabrera (32.8 percent for Marlins) Hall odds: 100 percent. Sixth-highest average (.318) of anyone with 450-plus homers.

4. Dwyane Wade (93.9 percent for Heat) Hall odds: 100 percent. Not being sentimental here. D-Wades a first-ballot lock.

5. Chris Bosh (47.0 percent for Heat) Hall odds: 97 percent. Cant penalize him because blood clots truncated his career late.

6. Ray Allen (13.3 percent for Heat) Hall odds: 95 percent. Career leader in three-point field goals should sail right in.

7. Brandon Marshall (18.0 percent for Dolphins) Hall odds: 60 percent. Has 941 catches for 12,061 yards, 82 TDs, but Cantons tough for receivers. Could use a couple of more big seasons.

8. Zach Thomas (91.7 percent for Dolphins) Hall odds: 45 percent. Still a fair chance hell be appreciated in time. Fast fact: Zach made more Pro Bowls (7-6) than newly inducted Taylor.

9. Gary Sheffield (21.9 percent for Marlins) Hall odds: 40 percent. Should be in already, with 509 home runs, a .907 career OPS and more RBI than 126 who are now in Cooperstown.

10. (tie) Tim Hardaway (44.0 percent for Heat), Bob Kuechenberg (100 percent for Dolphins) and The Marks Brothers (Duper 100 percent for Dolphins, Clayton 89.4 percent) Hall odds: 20 percent. Hoops Hall an easier ticket, which helps Hardaway. The overlooked guard Kuechenberg played more Dolphins seasons than anyone but Marino, and played and started more games than all but Marino and Taylor. The inseparable Duper and Clayton combined for 1,093 catches and 143 TDs as Marinos best buds, but wideouts have toughest path to Canton.

Thomas on the above list strikes an especially poignant note this weekend. Once, there was a hope and belief the two longtime teammates and brothers-in-law might enter Canton together. Then it became apparent Thomas was not held in the same historical regard. Now, this weekend, Thomas did not attend his former close friends Hall induction ceremony because of a family related estrangement. Taylor and wife Katina (Zachs sister) divorced in 2015, and she is now suing Taylor related to alimony payment.

On a brighter note, the current South Florida pro sports figures most likely to someday get the honor Taylor earned on Saturday:

1. Ichiro Suzuki (14.8 percent for Marlins) Hall odds: 100 percent. Baseball-reference.coms Hall of Fame Monitor calls a 100 rating a good possibility for induction and 130 a virtual cinch for Cooperstown. Ichiro is at 234.

2. Ndamukong Suh (29.2 percent for Dolphins) Hall odds: 75 percent. Five Pro Bowls, 47 sacks in seven seasons. And only 12 pure defensive tackles are in Canton, favoring his odds.

3. Coach Erik Spoelstra (100 percent for Heat) Hall odds: 60 percent. Already 38th with 442 wins, and seventh among those 38 with a .609 win percentage. Might take a third championship but at 47 hes just entering his coaching prime.

4. Roberto Luongo (48.3 percent for Panthers) Hall odds: 55 percent. Goaltender is hurt by zero Stanley Cup or Vezina Trophy wins. But second all-time in saves and fifth in games won gets you noticed.

5. Giancarlo Stanton (100 percent for Marlins) Hall odds: 40 percent. Yes, 241 homers at age 27 is a big start, but itll take a lot more big years for Stantons chances to go from possible to probable. Its tougher on sluggers.

6. Cam Wake (100 percent for Dolphins) Hall odds: 25 percent. With 811/2 sacks at age 35, wont have the career total Canton likes. But his story (coming to NFL at age 27 out of Canada, coming back from Achilles surgery) could resonate with voters.

7. Jarvis Landry (100 percent for Dolphins) Hall odds: 15 percent. See above. Has club-record 288 catches in three seasons, but also a modest 10.6-yard average and 13 total TD receptions.

8. (tie) Mike Pouncey (100 percent for Dolphins), Hassan Whiteside (91.6 percent for Heat) and Sasha Barkov (100 percent for Panthers) Hall odds: 10 percent. Pouncey has three Pro Bowls at a speciality position (center) but cant stay healthy. Whiteside has all the physical gifts but already is 28. Barkov is still a baby at 21, but oh the long-term potential!

The above list is missing someone, of course. A name glaring for its absence. Jose Fernandez, the late Marlins ace, would be on it, likely ranked second or third, had a boating tragedy last September not erased his future.

Perhaps not since Red Sox slugger Tony Conigliaro in the late 1960s had a rising sports star of such promise seen a potentially Hall of Fame-headed career end so suddenly in tragedy.

All of the ways it can deny you is a part of any Hall of Fames mystique, and what makes the entrants so grateful they have had the life not just the career that allows it.

Read the rest here:
Immortality calling: Who'll be next Dolphins, Heat, Marlins or Panthers star in Hall of Fame? - Miami Herald (blog)

Eli building chemistry with new targets – Giants.com (blog)

QB Eli Manning has been establishing a connection with newcomers in the receiving corps: EAST RUTHERFORD, N.J. Eli Manning is establishing a clear connection with the Giants newcomers who will be two of his most frequent targets this season.I think were doing some good stuff, Brandon (Marshall) and I, getting on the same page, Manning said today. Every day theres something new that comes up, though. A route here, a concept, just getting on the same timing. You can kind of talk about everything, but youve got to get in as many live reps, one-on-ones, get running different routes, getting on the same timing with things will be good. Same with (tight end) Evan (Engram, the teams first-round draft choice). Hes making some plays, doing a lot of good things, but the more one-on-ones, the more situations, different things coming up every practice. Theres something to learn from it every day.

>> VIEW GIANTS FIRST UNOFFICIAL DEPTH CHART

Marshall, a 12-year veteran, is already a major presence in the wide receivers and offensive meeting rooms.

Brandons been great, Manning said. Every day trying to learn, always has questions for me and were trying to figure out what he can do better, how we can get on the same page. So I think hes been dialed in and been a great leader and just setting the example for how to be prepared for every practice.

I think hes a tremendous communicator, coach Ben McAdoo said of Marshall. I found that out the first time I met with him, we had a nice conversation, we sat down one-on-one and talked about what we wanted to get out of this, on both sides. Hes a guy that speaks from the heart and hes a tremendous communicator and I think thats rubbing off on some guys in the room.

One thing Marshall cant give to the other receivers is his size. At 6-5, he stands two inches above the next-tallest receiver, rookie Jerome Lane. The other starters are 5-11 Odell Beckham, Jr. and 5-10 Sterling Shepard.

Manning hasnt had such a tall wideout to throw to regularly since 6-5 Plaxico Burress, who was a Giant from 2005-08. In his first season here, Burress caught 76 passes for 1,214 yards and seven touchdowns, figures Marshall certainly hopes to exceed this year.

Theyre both similar height, Manning said. And just smarts on football, body control, being able to go up and get the ball. So yeah, Id say some definite similarities there. Obviously, Plaxico, had a number of years playing with him, so I knew what he was going to do, knew how to read his body. I knew whether it was going to be a back shoulder versus a fly or a jump ball. So we need more live reps doing that.

Those big guys, you have an opportunity to throw them open. They can be physical at the line of scrimmage and get some separation that way, where the quick guys make moves. So Brandon does a good job finding ways to get open. Whether its being physical with the DBs, or throwing the back shoulders, throwing the fly routes, going up and get the ball. I can always just have separation with the quick guys, but theyre still getting open in a different way.

Engram is no slouch in the height department at 6-3. But in addition to picking up the offense, he is learning how to be a successful NFL player, which Marshall learned years ago. Manning tries to help his fellow Ole Miss alum without oiling on too much information.

I think its a little bit of both, he said. You dont want to baby him too much, you want to see what he can gather. You want to give him a little heads up of what might be coming, though. Dont just surprise a bunch of things on him, so in practice hes scared, or a little lost, or indecisive. So give him a heads up of what might be coming, talk a lot through to him and then see what he can handle. You want to be prepared for the upcoming season, you dont want to be held back and say, Hey, I cant check into a certain play because you might not know what it is. You need to know what everything is, based on whats in the system.

*Other Manning musings four days before the Giants preseason opener vs. Pittsburgh:

*He did not play in the first and last preseason games in 2016. Did he get enough action to prepare for the season?

I think I got enough action over the last 14 years to get me ready for the upcoming season, he said.

*Was it an adjustment to get fewer preseason snaps?

Whatever Coach wants to do, what he thinks is best for me, the team, Im going to do, Manning said. Again, for the first preseason game, you might take six or seven snaps. So its not like its going to make a difference for that upcoming season. I think youve got enough reps in practice, enough reps in the second and third (preseason games) and obviously 13 other years of preseason and regular season games should get me in good rhythm.

*On whether the videos that have surfaced of the players dancing in the locker room is a sign that players are loose and close with one another:

Theyre having fun, Manning said. Thats always training camp, theres going to be different things. Youve got to enjoy this time, it is a lot of practice, its a lot of meetings, it is hard work and there are hot days and those things. But theres always those little 30-minute stretches where you have down time and guys get to mess around. It used to be, you did it at night, or you did it when you were in the dorm rooms, or hanging out, or playing pranks. Now, theres not much time at the hotel. You get done late and youre kind of back in your room. So, that time has kind of come into the locker room during the day, where you get little breaks, where I guess theyve turned into dance parties now. So thats the new thing.

Follow this link:
Eli building chemistry with new targets - Giants.com (blog)

Martin and Short bring their chemistry to the masses – San Francisco Chronicle

By Peter Hartlaub

Martin Short and honoree Steve Martin walk the red carpet at the 43rd AFI Life Achievement Award Gala honoring Martin at Dolby Theatre on June 4, 2015 in Hollywood.

Martin Short and honoree Steve Martin walk the red carpet at the 43rd AFI Life Achievement Award Gala honoring Martin at Dolby Theatre on June 4, 2015 in Hollywood.

Steve Martin (left) plays George and Martin Short plays Franck the flamboyant and officious wedding planner in "Father of the Bride."

Steve Martin (left) plays George and Martin Short plays Franck the flamboyant and officious wedding planner in "Father of the Bride."

Martin and Short bring their chemistry to the masses

Steve Martin and Martin Short are associated with a lot of locations far outside the Bay Area: Canada, Los Angeles, Live from New York

But when asked to share any memories provincial to San Francisco, both comedy legends come up with a long and poignant formative story from the mid-1960s. Martin drove up from L.A. and slept in his Volkswagen van as an 18-year-old, performing some of his first paid gigs in North Beach. And San Francisco was the first U.S. city that Canada-born Short visited, at age 15.

My sister Nora was a nurse in San Francisco, and my mother and I went down, Short says. They snuck me into the hungry i (nightclub). We saw Joan Rivers opening for Carmen McRae. It was the most exciting thing to be in San Francisco in 1965 and going to these hip clubs.

Martin and Short will return in spirit, if not the city limits on their latest comedy tour; a two amigos variety show that arrives at the Concord Pavilion on Friday, Aug. 11.

The comedians talked about their friendship during a phone interview last month. The conversation was stilted at times, in part because Short was calling from Ontario, Canada, and Martin from Santa Barbara. But their chemistry comes through, even on a three-way conference call.

Their first appearances on Saturday Night Live were nearly a decade apart, and Shorts early comedy roots (including SCTV in Canada in 1982-83) didnt offer much crossover with Martin, who had by the early 1980s become a Hollywood star.

They met in the spring of 1985, when Short went to Martins house to pick up a script for Three Amigos, a 1986 feature film comedy with Chevy Chase.

Lets put it this way. Maybe three weeks into the movie, I felt like I had a new friend that I really liked, Martin says. I didnt know if he liked me, but I liked him.

They maintained their friendship, appearing together in the Father of the Bride movies in the 1990s, and after that during random red carpets, charity benefits and late-night talk show guest spots. But their careers were often in different spheres, with Short pursuing stage and television projects such as Primetime Glick, and Martin starring in movies and touring with the bluegrass band the Steep Canyon Rangers.

A 2011 conversation between Short and Martin at the Just For Laughs festival in Montreal led to a tour, where the pair interviewed each other and took questions from the audience. Now their show has developed short gags, a video presentation, music and other random parts.

We just kept adding, Short says. The conversation ... certainly worked, and thats when we were reminded of our natural chemistry with each other. Then we just started adding bits and adding routines and adding ideas, and it just evolved into a kind of a hip variety show.

About 25 minutes of the two-hour show is musical, with Martin playing bluegrass, and Short showcasing one of his more underrated talents: his voice.

Martin says hes continually impressed with Short, who won a Tony Award for his work in the Neil Simon musical Little Me in 1999, and later played Leo Bloom in The Producers in Los Angeles.

I knew it, but I didnt know it, Martin says. Hes a terrific singer. I can only think of one other person whom I toured with, with the same kind of solidity, and that was Karen Carpenter.

Short and Martin have crossed the country several times together, but theyre eager to get the conversation back to San Francisco. Martin says San Francisco newspapers have always been good to me, mentioning a 1972 rave by Chronicle critic John Wasserman, when Martin was starting a career-boosting run at the Boarding House.

He was in San Francisco years before that, driving up as early as 1963.

I would drive up from L.A. to San Francisco, get the cheapest hotel possible, or live in my VW van, Martin says. I remember passing the Purple Onion (and hungry i). There would be Lenny Bruce playing there and Mort Sahl playing there, and whoever the Smothers Brothers playing there and the Kingston Trio.

Martin says one of his first paid comedy performances was at the Coffee Gallery in San Francisco, next door to former Beat Generation landmark Coffee and Confusion in North Beach. He offers a sober account of his performances there sometimes for a crowd of no one.

But with this pair, its never serious for long. Asked if these larger crowds on the Martin and Short tours shout out requests, the pair settle into a nice self-deprecating comic groove.

The show is very tight. Theres hardly any room for anyone to shout out anything. Were always talking, Martin says.

Particularly Bravo! Short quips.

Theres definitely no room for Bravo, Martin says.

Peter Hartlaub is The San Francisco Chronicles pop culture critic. Email: phartlaub@sfchronicle.com Twitter: @PeterHartlaub

Steve Martin and Martin Short: 8 p.m. Friday, Aug. 11. $37.50-$183. Concord Pavilion, 2000 Kirker Pass Road, Concord. (925) 676-8742. http://www.livenation.com

View original post here:
Martin and Short bring their chemistry to the masses - San Francisco Chronicle

Magnetic microbot traps single cell – Chemistry World (subscription)

A tiny robot that can capture a single cell has been made by scientists in the US. The microbot is made of metal-coated plastic cubes, which allow it to open and close using magnetic energy.

Microrobotic devices could one day perform surgery in places where large instruments cant reach, like inside the smallest blood vessels. [It] is one of the dreams in translational medicine, to assemble microsurgeons in vivo, says microrobot researcher Mahmut Selman Sakar from the Swiss Federal Institute of Technology in Lausanne, who wasnt involved in the study.

While the team led by Gabriel Lpez from Duke University and Orlin Velev from North Carolina State University has not yet achieved this, their modular microbots are already agile enough to trap a 4m yeast cell, move and then release it again. Made out of individual polymer cubes coated on one side with metallic cobalt, the microbots store energy from an external magnetic field and release it when the field is switched off.

The cube shape means that you can have two different configurations two cubes have their coating either on the same [AA] or on opposite [AB] sides, explains Velev. Depending on the cubes sequence, the microbot can carry out different tasks an ABBA bot, for example, is the simplest grabber. It opens when a magnetic field is applied and closes when the field is switched off. The fields gradient and orientation then control the bots movement and rotation.

In the future, the microbots could do more than simply trap objects. We now have a microtool to investigate mechanical properties on the microscale, Velev says. His team has started investigating liquid crystals, using the grabber to squeeze them and establish microscale mechanical forces.

Sakar suggests that the microbots could find applications in microfluidics: You could inject microscale particles into a microchannel and then, using external magnetic fields, bring them together and make a little rotor-shaped object, and spin it to create a fluidic flow for mixing mixing is a hard task at small scale due to low Reynolds number.

Currently, Velev and Lpez make each microbot by adding one cube at a time. Velev suggests that templating using a functionalised surface to direct the cubes into place could speed up fabrication. Eventually, microbots might even be able to replicate on their own. Right now, we have to design and build every single tool ourselves, says Sakar, but it would be fascinating if the tools could then build more tools by themselves.

Continued here:
Magnetic microbot traps single cell - Chemistry World (subscription)

SSRN Launches ChemRN – A New Network Dedicated to Chemistry – Markets Insider

ROCHESTER, New York, August 7, 2017 /PRNewswire/ --

Elsevier, the information analytics business specializing in science and health, announces SSRN, its world leading working paper repository and preprint server, today launches the Chemistry Research Network - ChemRN.

The launch of ChemRN follows hot on the heels of the BioRN launch in June 2017, SSRN's new network dedicated to biology and its first outside the social sciences. BioRN already has nearly 5,000 papers live from approximately 6,500 authors.

Gregg Gordon, Managing Director of SSRN, said: "The launch of ChemRN is part of our strategy to extend the expertise and knowledge we have in building community driven networks to benefit even more people in the research community. It's been a little over a month since we launched BioRN, our network dedicated to biology research. It has been a huge success and we look forward to ChemRN being just as a popular."

Chemistry researchers can share ideas and other early stage research, including posting preprints and working papers on ChemRN. Users can quickly upload and read papers for free, across all of Chemistry, including the fields of Energy, Environmental and Materials Sciences.Join Gregg's live webcast on August 17.

Chemistry researchers can post preprints and working papers on ChemRN, share ideas and other early stage research, and collaborate. It allows users to quickly upload and read abstracts and full text papers, free of charge.

A preprint is the author's own write-up of research results and analysis that has not been peer-reviewed, nor had any value added to it by a publisher (such as formatting, copy-editing, technical enhancements). A preprint server, or working paper repository as they are also known, allows users to share these documents.

SSRN has been serving the research community since 1994 and was acquired by Elsevier in May 2016. Since joining Elsevier, SSRN has completely redesigned its website making it cleaner and easier to use. It has also launched full-text search. SSRN is now working towards deeper integration with Elsevier's other research products, particularly Mendeley's reference management software and Pure's research management system.

Read more on Elsevier Connect.

Interviews with Gregg Gordon, Managing Director of SSRN, are available on request.

About SSRN

SSRN is a worldwide collaborative of over 350,000 authors and more than 2.2 million users that is devoted to the rapid worldwide dissemination of research. Founded in 1994, it is now composed of a number of specialized research networks. Each of SSRN's networks encourages the early distribution of research results by reviewing and distributing submitted abstracts and full text papers from scholars around the world. SSRN encourages readers to communicate directly with other subscribers and authors concerning their own and other's research. Through email abstract eJournals SSRN currently reaches over 400,000 people in approximately 140 different countries. http://www.ssrn.com

About Elsevier

Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries.www.elsevier.com

Media contactDavid TuckerGlobal Communications, Elsevier+44-(0)-7920-536-160rel="nofollow">d.tucker@elsevier.com

Read the original post:
SSRN Launches ChemRN - A New Network Dedicated to Chemistry - Markets Insider

McKewon: More players communicating as younger Husker football … – Omaha World-Herald

LINCOLN No word yet on whether itll win any more games, but the 2017 version of Nebraska is a bigger democracy among teammates than in recent seasons.

Its a lot more free, junior left guard Jerald Foster said. Youre able to get your word in. If you have something thats really going to help out an older guy, just say it. Get it going. Im happy with what were doing right now.

Previously, Foster said, the seniors would talk and everybody else would sit back and listen to what they say.

Since that large senior class left after the Music City Bowl, it changed. Sure, Foster said, the true freshmen dont know the lay of the land. But redshirt freshmen are able to get a word in.

On a team as young and inexperienced as Nebraska, thats logical. Conventional wisdom about team building suggests that this squad might still be finding its way in terms of chemistry, culture and player leaders.

Coach Mike Riley sees just the opposite. The first week of training camp, he said, was seamless. Two practices viewed by reporters revealed much the same. Riley credited the player leaders, many of whom werent leaders in previous years.

Theres no doubt that talent is respected, and that can cloud that real leadership deal sometimes, Riley said. But with this group, I dont have to worry about anybody being misguided in that way. When your good players are doing the right thing and working at the highest level, thats what you have to have.

Riley likes it when he can steer young players toward the veterans and say, Watch how he does it. When the players, Riley said, are the main teachers. Sometimes hell call them magnets.

On Saturday, Riley pointed to inside linebackers Chris Weber and Dedrick Young as examples. Weber is a sit-in-the-front-of-the-class walk-on. Young is a shy interview who may be more chatty with his teammates, but is far from a screamer.

Theres guys who are dynamic about lets go, but theyre not overly dramatic, Riley said. Theyre just great example guys. Those two inside linebackers, you just dont have to worry about those guys. The football phase, the school phase, life. To me, thats tremendous leadership. They do everything theyre supposed to do.

Its hard not to contrast that with a 2016 captain who was suspended for the first and last games of the season because of academic issues. Or the 2015 captain who went on a Twitter rant after the loss to Miami, suggesting fans would kiss my feet. A few weeks later, he blew sarcastic kisses to fans after a loss to Illinois. He got to remain captain.

Nate Gerry and Alex Lewis are going to play in the NFL a long time, Id bet. It wouldnt surprise me if both make Pro Bowls one day.

But this Husker squad less experienced than either of those teams and facing what I think is a harder schedule needs as much smooth, seamless practice as it can get, especially as camp drags into that fourth week, when guys start school but are 12 days away from a game.

Coaches, players and training staff were prescient in understanding this team would need great chemistry. So it set up those offseason conditioning groups, with 11 captains, to help. And it appears to have worked. It probably benefited quarterback Tanner Lee the most; installed as a group leader months ago, Lee built up cachet with his teammates.

Hes a workaholic, receiver DeMornay Pierson-El said of Lee.

Pierson-Els on-field story is interesting, perhaps more so than any current Huskers. As a freshman, he was a big part of that final Bo Pelini team. The edge that Pierson-El plays with easily fit into the old Bo-to-the-troops leadership paradigm.

Like all players under Riley, Pierson-El has more personal freedom to figure out where he fits in, and coupled with two injuries and a slow road back to full health, he seemed a little restless. At times last season he seemed, to this reporters eyes, to press a little. Like Jamal Turner used to, and not just trust that he was as good of an athlete as he was.

You sensed a big jump in the spring. Pierson-El had that extra gear back and he shifted into it often. His routes were cleaner and more exact; he seemed more confident Lee was delivering the ball where Pierson-Els route was actually headed. Nebraska needs Pierson-El at the top of his game; this is not a deep receiving corps.

Though Pierson-El said hes never been shy to speak up if something needed to be said, his answer about how he views his senior season is a portal into what might happen. Getting back to the basics and just having fun, for real, for real, Pierson-El said. Enjoy myself, let things come to me, have a blast and enjoy the team, friends. Just have fun.

Young guys speaking up. Seniors trying to find a good groove.

Its a different culture inside Nebraska football.

Five stats

Three: Years since Nebraska has been ranked in the preseason Top 25, in either the coaches or Associated Press poll. NU received votes in the coaches poll in 2017, but fell short of the Top 25. I dont expect the AP to be any kinder. In 2014, NU was No. 22 in both polls to start the season. In 2013, the Huskers were 18th in both, and 17th (AP) and 16th (coaches) in 2012.

Five: Ohio State Buckeyes projected in the first round of NFL analyst Matt Millers 2018 mock draft. Miller, who writes for Bleacher Report, has long been one of the scouts I follow. Four of the five Buckeyes play defense, and two (end Sam Hubbard and tackle DreMont Jones) play on the defensive line. There may never be a better defense than 2011 Alabama which gave up 8.2 points and 184 yards per game but this OSU unit could make a run at 10 points and 250 yards, if it finds a way to slow down Oklahoma.

6.26: Average number of Nebraska penalties per game since joining the Big Ten. Over that same time, Wisconsin has averaged 4.42 penalties per game. Iowa averaged 4.52 penalties per game. Fewer penalties doesnt always mean better teams, but its interesting to compare the three teams.

Minus-10: Nebraskas penalty margin in its last six games against Wisconsin and Iowa. NU has committed 39 penalties in those six games while Wisconsin (13) and Iowa (16) have committed a combined 29 penalties in those games.

Minus-105: Nebraskas penalty yardage margin in those six games. Divided over six games, thats 17.5 yards, or roughly two first downs. NU is 1-5 in those games.

Opponent watch

You may remember last week when I wrote about Penn State embracing a quick-tempo spread offense and riding that to a Big Ten title. Under P.J. Fleck, Minnesota is going to run a similar style of offense, and its practices are being run at a furious tempo to accommodate it.

We get in 90 plays a day within an hour and 20 minutes, Gopher Carter Coughlin told the Minneapolis Star-Tribune. That tempo is honestly faster than a game tempo, so its preparing us for a game. Its going to slow things down for us in a game.

Said Fleck: We condition during practice and put them in a lot of very tough positions in practice. We put them in situations that youd like to say will be harder here than in a game.

Flecks a lot of PR flash and catchphrases, but this thing how his offense runs is what will determine his success in Minnesota. Pay attention to that. Flecks betting on not needing four- and five-star recruits to win. Hes betting on his leadership style and this system. Im curious to see if it works.

According to the Daily Chronicle, Northern Illinois opened its camp at 5:30 a.m. Tuesday. The Huskies have a three-man quarterback race, and one player is Chad Beebe, whose last name might ring a bell: His dad, Don Beebe, played in the NFL for the Bills and at Chadron State.

Forecast

After a week of all smiles, Im guessing the training camp grind starts to settle in.

As a freshman, Husker wide receiver De'Mornay Pierson-El had 1,090 all-purpose yards, including 596 on 34 punt returns, 147 on on 10 kickoff returns, 321 on 23 receptions, 16 on one completion and 10 on five rushing attempts. Do you think he'll break that total this y
ear?

Back

Get a daily Husker news roundup, recruiting updates and breaking news in your inbox.

Husker football coach Mike Riley greets players.

Husker linebacker Willie Hampton stretches.

Husker wide receiver Jaevon McQuitty stretches.

Husker defensive back Dicaprio Bootle runs through drills.

Husker Mikale Wilbon walks onto the practice field.

Husker wide receiver Stanley Morgan, left, and defensive back Dicaprio Bootle greet each other.

Husker kicker Drew Brown practices his field goals.

Husker wide receiver Conor Young runs through drills.

Husker linebacker Mohamed Barry stretches.

Husker defensive lineman Peyton Newell walks onto the outdoor field.

Husker Zack Darlington holds for kicker Drew Brown.

Husker quarterback Tanner Lee warms up before the start of practice.

Husker running back Mikale Wilbon warms up before practice.

Husker Caleb Lightbourn punts a ball during practice.

Husker defensive line coach John Parrella talks with his players during practice.

Husker offensive line coach Mike Cavanaugh works with his players during practice.

Husker offensive lineman Nick Gates arrives for practice.

Husker defensive linemen Mick Stoltenberg, left, and Matt Jarzynka walk onto the field.

Husker wide receiver De'Mornay Pierson-El.

Banners commemorating Nebraska's five national championships hang in the Hawks Championship Center.

Husker football coach Mike Riley greets players.

Husker linebacker Willie Hampton stretches.

Husker wide receiver Jaevon McQuitty stretches.

Husker defensive back Dicaprio Bootle runs through drills.

Husker Mikale Wilbon walks onto the practice field.

Husker wide receiver Stanley Morgan, left, and defensive back Dicaprio Bootle greet each other.

Husker kicker Drew Brown practices his field goals.

Husker wide receiver Conor Young runs through drills.

Husker linebacker Mohamed Barry stretches.

Husker defensive lineman Peyton Newell walks onto the outdoor field.

Husker Zack Darlington holds for kicker Drew Brown.

Husker quarterback Tanner Lee warms up before the start of practice.

Husker running back Mikale Wilbon warms up before practice.

Husker Caleb Lightbourn punts a ball during practice.

Husker defensive line coach John Parrella talks with his players during practice.

Husker offensive line coach Mike Cavanaugh works with his players during practice.

Husker offensive lineman Nick Gates arrives for practice.

Husker defensive linemen Mick Stoltenberg, left, and Matt Jarzynka walk onto the field.

Husker wide receiver De'Mornay Pierson-El.

Banners commemorating Nebraska's five national championships hang in the Hawks Championship Center.

See the original post:
McKewon: More players communicating as younger Husker football ... - Omaha World-Herald

The return of chemical weapons? – Chemistry World (subscription)

Civilians in Syria were exposed to the nerve agent sarin in April, the Organisation for the Prohibition of Chemical Weapons (OPCW) confirmed at the end of June. This was the second documented use of sarin in Syria, and follows cases of chlorine and mustard gas being used as weapons. So can the world expect to see more chemical warfare?

There is a lot of concern within the OPCW, says Alastair Hay, professor of environmental toxicology at the University of Leeds, UK. If the Chemical Weapons Convention (CWC) cant be upheld, and perpetrators held accountable, then that is a problem.

Syria crossed President Obamas red line in 2013 when it used chemical weapons in Ghouta, and, although the threatened US retaliation did not happen, the result was that Syria reluctantly joined the CWC. Hay doesnt think that Syria will use chemical weapons again, because it will be wary of triggering further US missile attacks following those ordered by President Trump in response to the April attack. The gains are marginal, while the outcry is huge, he says.

If the Chemical Weapons Convention cant be upheld, and perpetrators held accountable, that is a problem

Alastair Hay, University of Leeds

Tim Eaton, research fellow with the Middle East and North Africa Programme at Chatham House, agrees that Trumps military response will make Syria hesitate before using chemical weapons again. Now Trump has threatened heavy retaliation if they use sarin again. This is the first time that the Assad regime has been punished materially for human rights abuses in this conflict.

However, security consultant Dan Kaszeta believes Syria will use chemical weapons again, eventually. Trump is a roulette wheel, the least predictable leader on the world stage at the moment, and so he has no deterrent value.

Weapons expert Richard Guthrie also worries that there are significant implications if no one is held to account for the use of sarin in Syria. As it stands today, one lesson of Syria that could be drawn by other dictatorships is that a chemical weapons programme may buy you time within a civil war. If fear of being deposed, or getting caught and brought to trial, are the major disincentives to using chemical weapons, then the Syria case has illustrated neither of them.

Another security threat, says Eaton, is the potential of non-state actors, such as terrorist organisations, to obtain chemical weapons technology, particularly in ungoverned or contested areas. This is seen as a greater threat than a state using chemical weapons.

Hay agrees that there are indications that some terrorist organisations are considering using chemical weapons, but so far there is only one instance verified by the OPCW which was ISIS using mustard gas.

While the threat of countries using chemical weapons has diminished, chemical terrorism is no longer a theoretical proposition or even imminent threat, but a stark reality, says OPCW Director General Ahmet zmc. The OPCW describes various scenarios for chemical terrorism including non-state actors acquiring chemical weapons through the black market, illicit trade or theft; acquiring or producing chemical agents then deploying them with improvised devices; finding ways to disperse industrial chemicals, or contaminating the food chain, for example with ricin.

chemical terrorism is no longer a theoretical proposition or even imminent threat, but a stark reality

Ahmet zmc, OPCW Director General

The organisation notes terrorists still need to overcome the challenges of producing chemical agents, which involves having the right expertise, equipment and facilities, and sufficient funds. The least scientifically demanding scenario involves the use of industrial toxic chemicals, such as chlorine, which is widely available on the commercial market in large quantities and is relatively easy to disperse.

Hay agrees that, in terms of making new weapons, such as nerve agents, there are several barriers. Turning them into weapons requires expertise that is not widely available outside the military. While chlorine is easier to obtain, non-state actors are limited by their lack of aircraft or weaponry with which to deliver it as a weapon. Whats more, it would be hard for them to get hold of sufficient quantities to have an effect. The OPCW has destroyed almost 95% of global stockpiles, and is working with the chemical industry to secure and police their stocks. Hay believes access to major stocks is now reasonably well controlled.

For Kaszeta, the main reasons that both states and non-state actors are unlikely to use chemical weapons in future are because they are impractical, unaffordable and ineffective. To make one ton of nerve agent you need 9-10t of precursors which OPCW control and then youre left with 8t of toxic waste. You need a testing and evaluation programme, and military-trained personnel Chemical weapons are obsolete for a reason. The message should be: they just arent worth the bother.

But Guthrie is not so positive. He highlights four key risks and threats around future chemical weapon use: governments outside of the CWC possessing weapons (Egypt, Israel, North Korea and South Sudan are all non-signatories); national controls on relevant materials and technologies varying between countries; lack of capacity to attribute attacks to the perpetrators; and a complacency that international conventions will deal with problems.

But perhaps the greatest political challenge, he says, is maintaining political focus. [Syrias sarin attacks] brought a huge amount of political attention, but most of this has faded now.

The challenge of preventing the use of [chemical weapons] will go on for longer than the lifetime of individual governments.

Read more from the original source:
The return of chemical weapons? - Chemistry World (subscription)

Jennifer Cochran appointed chair of bioengineering – Stanford Medical Center Report

Jennifer Cochran, PhD, has been appointed chair of Stanfords Department of Bioengineering, which is jointly operated by the School of Medicine and School of Engineering. Her five-year term begins Sept. 1.

This department has an amazing energy due in no small part to its faculty, students and staff, said Cochran, associate professor of bioengineering. These individuals nearly 500 of them, in all have an unwavering commitment to research, learning and service, and they exude a spirit of collegiality and collaboration that permeates our department and the broader Stanford community.

Cochrans research is interdisciplinary, integrating chemistry, engineering and biophysics. Her laboratory focuses on protein-based drug discovery for applications including oncology and regenerative medicine, and the development of new technology for high-throughput protein analysis and engineering.

In addition to being a superb scholar and educator and a proponent of deeper connections with Silicon Valleys burgeoning biotechnology activities, Jennifer is an enthusiastic, dynamic individual who will bring exciting leadership to the department and be a key contributor to the schools of Engineering and Medicine, Lloyd Minor, MD, dean of the School of Medicine, and Jennifer Widom, PhD, dean of the School of Engineering, said in a joint statement.

Cochran will succeed Norbert Pelc, ScD, professor of bioengineering, who has chaired the department since 2012. Norberts vision and leadership has brought the department to new heights, Minor and Widom said. The remarkable strength of our still relatively new Bioengineering Department reflects Norberts tireless work and deep dedication.

Cochran earned a PhD in biological chemistry from the Massachusetts Institute of Technology in 2001. After a postdoctoral fellowship at MIT in biological engineering, she arrived at Stanford in 2005 as an assistant professor of bioengineering. In 2012,she was promoted to associate professor.She also advises cancer biology and biophysics graduate students and serves as director of the Stanford National Institutes of Health Biotechnology Predoctoral Training Program and as co-director of the Stanford National Institute of Standards and Technology Predoctoral Training Program.

Continue reading here:
Jennifer Cochran appointed chair of bioengineering - Stanford Medical Center Report

Zachary Ball to Lead Institute of Biosciences and Bioengineering – Texas Medical Center (press release)

Rice University chemist Zachary Ball has been named director of Rices Institute of Biosciences and Bioengineering (IBB). The institute promotes interdisciplinary research and education encompassing physics, chemistry, biology and engineering.Ball succeeds Jane Grande-Allen, who will continue to serve as the Isabel C. Cameron Professor and chair of the Department of Bioengineering.

Zach is our first chemist in the role of IBB director and I am very excited about how he will expand the scope of our collaborative research, said Yousif Shamoo, Rices vice provost for research, who announced the appointment.

Ball sees his role with IBB as an opportunity to soften boundaries between departments at Rice and to help faculty connect with outside researchers in the Texas Medical Center.

There is this inherent tension at a university, Ball said. We still need a traditional department structure, but theres also a need to empower faculty in ways that are bigger and broader than traditional departments can provide. Thats a big reason why IBB is and remains a hugely important part of the Rice research ensemble. Its uniquely situated to encourage faculty collaboration.

Zach brings an objective clarity on integration, said Paul Cherukuri, IBBs executive director. He has a great analytical understanding of all the things were doing at IBB and how to integrate our activities across the disciplines.

Ball used his own recent experience at Rice as an example. Since my lab moved to the BioScience Research Collaborative, weve been near new people and its really changed how we think about some research problems, he said. I see on a small scale how bringing together people with different views can help build research that goes in new directions.

Balls Rice lab designs, builds and studies novel transition-metal complexes with unique structures and functions for applications in chemical biology and medicine, including the development of next-generation protein drugs.

Im a chemist who clearly works on biological problems, but Ive also traditionally viewed myself as on the fringes of what IBB does, he said. So I think its both a strength and a challenge that I arrive at IBB with a different perspective. Ill try to use that unique perspective while also relying on the strong network of IBB faculty to effectively enable progress in the many diverse fields that IBB encompasses.

Ball, an associate professor of chemistry, joined the Rice faculty in 2006. He earned a bachelors degree at Harvard University in 1999 and a Ph.D. at Stanford in 2004.

Read more here:
Zachary Ball to Lead Institute of Biosciences and Bioengineering - Texas Medical Center (press release)

3D printing saves $2700 per surgery finds new research – 3D Printing Industry

Using 3D printing, a team from the University of California San Diego and Rady Childrens Hospital has reduced surgery time by approximately 25 percent.

The project focused on treatment of the most common hip disorder occurring in children aged between 9 and 16. The finding of the study are published in the Journal of Childrens Orthopaedics.

Engineers working together with pediatric orthopedic surgeons created surgical planning models using a 3D printer. The study compared the operating time on 5 patients where the 3D printed models were used to a control group of a further 5 patients.

Dr. Vidyadhar Upasani, pediatric orthopedic surgeon at Rady Childrens and UC San Diego, is the lead author of the study. Speaking about the results he said, Being able to practice on these 3D-models is crucial, said and the papers senior author.

Saving money and time with 3D printing

The study calculates that by using a 3D printed model to plan the surgery the time savings translate into a cost saving of $2700 per surgery. The models were produced using a moderately priced 3D printer costing $2200. The material cost for each model was approximately $10.

The research looked at a condition called slipped capital femoral epiphysis. This condition causes the patients femur to move against the bones growth plate leading to deformation. Surgery is required to remove part of the femur and help restore hip function.

Performing this task in the operating room can be problematic as the areas of focus are not directly visible. Therefore using a 3D printed model to understand the anatomy and challenges of a particular operation in advance is desirable.

Prior to adopting this new approach surgical teams would use X-rays for planning and also during the operation. Using X-ray fluoroscopy in the operating room was not only time-consuming, but also meant additional exposure to radiation for the patient.

Future research goals

The work was performed in conjunction with Jason Caffrey, Ph.D. candidate in bioengineering at UCSD, and Lillia Cherkasskiy, currently studying for an M.D. Bioengineering professor Robert Sah, and colleagues were also assisted with the study.

Input data for the 3D prints came from CT scans of the patients pelvis. A computer model was then created to visualize the bone and growth plate.

Seeing the benefit of 3D printing, Rady Childrens orthopedics department now has its own 3D printer. Dr. Upasani said. Ive seen how beneficial 3D models are, he said. Its now hard to plan surgeries without them.

Members of the research team are now investigating 3D printed models to assist in the treatment of infant hip dysplasia.

For all the latest news about 3D printing in healthcare, follow our active social media sites and sign up to the 3D Printing Industry newsletter.

Our 3D printing jobs is launching soon. You can register here.

The rest is here:
3D printing saves $2700 per surgery finds new research - 3D Printing Industry

Virtual competitors vie for a different kind of athletic title | Stanford … – Stanford University News

Modeling the walk

Kidziski works in the lab of Scott Delp, a professor of bioengineering and of mechanical engineering who has spent decades studying the mechanics of the human body. As part of that work, Delp and his collaborators have collected data on the movements and muscle activity of hundreds of individuals as they walk and run.

With data like that, Delp, Kidziski and their team can build accurate models of how individual muscles and limbs move in response to signals from the brain.

But what they could not do was predict how people relearn to walk after surgery because, as it turns out, no one is quite sure how the brain controls complex processes like walking, let alone walking through the obstacle course of daily life or relearning how to walk after surgery.

Whereas weve gotten quite good at building computational models of muscles and joints and bones and how the whole system is connected how the human machine is built an open challenge is how your brain orchestrates and controls this complex dynamic system, Delp said.

Machine learning, a variety of artificial intelligence, has reached a point where it could be a useful tool for modeling of the brains movement control systems, Delp said, but for the most part its practitioners have been interested in self-driving cars, playing complex games like chess or serving up more effective online ads.

The time was right for a challenge like this, Delp said, in part because some in the machine learning community are looking for more meaningful problems to work on, and because bioengineers stand to gain from understanding more about machine learning. His labs most successful efforts to model human movement have come from efforts to represent neural control of movement, Delp said, and machine learning is likely a realistic way to think about learning to walk.

So far, 63 teams have submitted a total of 145 ideas to Kidziskis competition, which is one of five similar contests created for the 2017 Neural Information Processing Systems conference. Kidziski supplies each team with computer models of the human body and the world that body must navigate, including stairs, slippery surfaces and more. In addition to external challenges, teams also face internal ones, such as weak or unreliable muscles. Each team is judged based on how far its simulated human makes it through those obstacles in a fixed amount of time.

Kidziski and Delp hope that more teams will join their competition, and with about two months remaining, they hope that at least a few teams will overcome all the various virtual obstacles thrown in their way. (No one has done so yet the top teams have for the most part conquered walking, but none has attempted the more athletic maneuvers.) The challenge, Kidziski said, is very computationally expensive.

In the long run, Kidziski said he hopes the work may benefit more than just kids with cerebral palsy. For example, it may help others design better-calibrated devices to assist with walking or carrying loads, and similar ideas could be used to find better baseball pitches or sprinting techniques.

But, Kidziski said, he and his collaborators have already created something important: a new way of solving problems in biomechanics that looks to virtual crowds for solutions.

Delp is the James H. Clark Professor in the School of Engineering and a member of Stanford Bio-X and the Stanford Neurosciences Institute. Graduate student Carmichael Ong, postdoctoral fellow Jason Fries, Mobilize Center Director of Data Science Jennifer Hicks and Mohanty Sharada coordinated the project. Sergey Levine, Marcel Salath and Delp serve as advisors

Go here to read the rest:
Virtual competitors vie for a different kind of athletic title | Stanford ... - Stanford University News

Path breaking – Gulf Times

Using a powerful gene-editing technique, scientists have rid human embryos of a mutation that causes an inherited form of heart disease often deadly to healthy young athletes and adults in their prime.The experiment marks the first time that scientists have altered the human genome to ensure a disease-causing mutation would disappear not only from the DNA of the subject on which its performed, but from the genes of his or her progeny as well.The controversial procedure, known as germ-line editing, was conducted at Oregon Health & Science University using human embryos expressly created for the purpose. It was reported in the journal Nature.The new research comes less than six months after the National Academies of Science, Engineering and Medicine recommended that scientists limit their trials of human germ-line editing to diseases that could not be treated with reasonable alternatives at least for now.In a bid to make the experiment relevant to real-life dilemmas faced by parents who carry genes for inherited diseases, the researchers focused their editing efforts on a mutation that causes inherited hypertrophic cardiomyopathy.In this genetic condition, a parent who carries one normal and one faulty copy of a the MYBPC3 gene has a 50-50 chance of passing that mutation on to his or her offspring. If the child inherits the mutation, his or her heart muscle is likely to grow prematurely weak and stiff, causing heart failure and often early death.In diseases where one parent carries such an autosomal dominant mutation, a couple will often seek the assistance of fertility doctors to minimise the risk of passing such a mutation on to a child. A womans egg production is medically stimulated, and eggs and sperm meet in a lab a process called in vitro fertilisation. Then embryologists inspect the resulting embryos, cull the ones that have inherited an unwanted mutation, and transfer only unaffected embryos into a womans uterus to be carried to term.In the new research, researchers set out to test whether germ-line gene editing could make the process of choosing healthy embryos more effective and efficient by creating more of them.In the end, their experiment showed it could. The targeted correction of a disease-causing gene carried by a single parent can potentially rescue a substantial portion of mutant human embryos, thus increasing the number of embryos available for transfer, the authors wrote in Nature. Co-author Dr Paula Amato, an Oregon Health & Science University (OHSU) professor of obstetrics and gynaecology, said the technique could potentially decrease the number of cycles needed for people trying to have children free of genetic disease if its found safe for use in fertility clinics.Along the way, though, many of the researchers findings were scientifically surprising. Long-feared effects of germ-line editing, including collateral damage to off-target genetic sequences, scarcely materialised. And mosaicism, a phenomenon in which edited DNA appears in some but not all cells, was found to be minimal.The studys lead author, OHSU biologist Shoukhrat Mitalipov, called these exciting and surprising moments. But he cautioned that there is room to improve the techniques demonstrated to produce mutation-free embryos. As for conducting human clinical trials of the germ-line correction, he said those would have to wait until results showed a near-perfect level of efficiency and accuracy, and could be limited by state and federal regulations.Eventually, Mitalipov said, such germ-line gene editing might also make it easier for parents who carry other gene mutations that follow a similar pattern of inheritance including some that cause breast and ovarian cancers, cystic fibrosis and muscular dystrophy to have healthy children who would not pass those genes to their own offspring.There is still a long road ahead, predicted Mitalipov, who heads the Center for Embryonic Cell and Gene Therapy at the Portland university.The research drew a mix of praise and concern from experts in genetic medicine.Dr Richard O. Hynes, who co-chaired the National Academies report issued in February, called the new study very good science that advances understanding of genetic repair on many fronts. Hynes, who was not involved with the latest research effort, said he was pleasantly surprised by researchers clever modifications and their outcomes.Its likely to become feasible, technically not tomorrow, not next year, but in some foreseeable time. Less than a decade, Id say, said Haynes, a biologist and cancer researcher at MIT and the Howard Hughes Medical Institute.University of California, Berkeley molecular and cell biologist Jennifer Doudna, one of pioneers of the CRISPR-Cas9 gene-editing technique, acknowledged the new research highlights a prospective use of gene editing for one inherited disease and offers some insights into the process.But Doudna questioned how broadly the experiments promising results would apply to other inherited diseases. She said she does not believe the use of germ-line editing as a means to improve efficiency at infertility clinics meets the criteria laid out by the National Academies of Science, which urged that the techniques only be explored as treatment for diseases with no reasonable alternative.Already, 50 percent of embryos would be normal, said Doudna. Why not just implant those?Doudna said she worried that the new findings will encourage people to proceed down this road before the scientific and ethical implications of germ-line editing have been fully considered.A large group of experts concluded that clinical use should not proceed until and unless theres broad societal consensus, and that just hasnt happened, Doudna said. This study underscores the urgency of having those debates. Because its coming.What is clear is that the researchers a multinational team of geneticists, cardiologists, fertility experts and embryologists from OHSU and from labs in South Korea and China tried a number of innovations in an effort to improve the safety, efficiency and fidelity of gene editing. And most yielded promising results.After retrieving eggs from 12 healthy female volunteers, researchers simultaneously performed two steps that had never been combined in a lab: At the same moment that they fertilised the eggs with the sperm of a man who carried a single copy of the mutated gene, they introduced the CRISPR-Cas9 repair machinery.The resulting embryos took up the genetic-editing programme so efficiently and uniformly that, after five days of incubation, 72.4 percent of the embryos (42 of 58) created and tested were free of the MYBPC3 mutation. By comparison, when sperm carrying the single mutation was used to fertilise eggs without any genetic manipulation, just 47.4 percent of embryos were free of the mutation linked to the deadly heart condition.The researchers believe the timing and the techniques they used prompted the embryos to rely on the healthy maternal copy of the gene as a model for fixing the MYBPC3 mutation, and not a repair template they introduced alongside the editing machinery when the eggs were fertilised. Only one of the 42 embryos used the introduced template for repair. The scientists contrasted this process to the DNA-repair mechanism operating in stem cells, which do use repair templates.As the embryos cells divided and they matured to the blastocyst stage the point at which they would usually be ready for transfer to a womans uterus they did so normally. After extensive testing, the embryos were used to make embryonic stem-cell lines, which are stored in liquid nitrogen and can be used in future research.Researchers also noted that genetic mosaicism a concern raised by earlier experimental efforts at gene editing was virtually absent from the 42 embryos that were free of the disease-causing mutation. Only one of the 42 embryos exhibited mosaicism, a condition in which cells did not all carry the same mutation-free genetic code.MITs Hynes said such findings offer important insights into how human embryos grow, develop and respond to anomalies, and will help families facing infertility and inherited illnesses.Human embryogenesis is clearly different from that of a mouse, which we know a lot about, said Hynes. That needs to be studied in human embryos, and theres no other way to do it.The results of the current study are not low enough yet for most applications certainly not for clinical applications, but its a big step forward, he added.While calling the new research very nice science, Hynes downplayed fears that germ-line editing would soon lead to tinkering with such attributes as looks, personality traits and intelligence in human children. Were not looking at designed babies around the corner not for a long time, he said.But we need to take advantage of the time and space we now have, he said, to make decisions about which uses of the technique are legitimate and which are not. Los Angeles Times/TNS

Go here to read the rest:
Path breaking - Gulf Times

Modification of genes in human embryos could mark turning point in human evolution – The Globe and Mail

It appears, by all accounts, to be a momentous scientific achievement and possibly a turning point in human evolution. In a study released last week, scientists at Oregon Health and Science University confirmed they were able to modify genes in viable human embryos, proving the potential to permanently alter the makeup of a genetic line.

In this case, that meant replacing and repairing a mutated gene that causes a common and deadly heart disorder. But the possibilities heralded by gene-editing technology are endless, the scenarios as divided as they are bold. In some visions, it leads to a population of designer babies or consumer eugenics. Others imagine a utopia of scientific advancement where humans live free of disease, and devastating conditions are eradicated for the betterment of humanity. What direction the technology will take is the topic of much debate.

The big thing which is making the scientific and ethics community get excited, and on the other hand a little bit hot and bothered, is its a mechanism to change genes for multiple generations, says Dr. Alice Virani, a genetic counsellor and director of ethics at British Columbias Provincial Health Services Authority. There are two ways to look at it, the more realistic ramifications and the sci-fi, if-this-was-out-of-control ramifications.

Opinion: Gene editing is not about designer babies

The team at the Oregon universitys Center for Embryonic Cell and Gene Therapy used technology called CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, to repair or edit the gene carrying the heart disorder, seemingly with greater success than previous attempts by scientists in China.

News of the research has been anxiously anticipated by many in the field, both for what it means for the potential eradication of a disease such as hypertrophic cardiomyopathy and for the fundamental questions it raises about human reproduction, health and society.

When the study was leaked days before its publication in the journal Nature, its lead scientist, Dr. Shoukhrat Mitalipov, attributed the release to likely a combination of hot words: CRISPR, gene-editing, and designer babies.

The study and its combination of hot words didnt disappoint.

The New York Times hailed the milestone in research, while The New York Post cried BABE NEW WORLD and described an amazing and slightly terrifying breakthrough. A headline on Vox declared simply, This Is Huge.

Even actor Ashton Kutcher tweeted enthusiastically about the scientific breakthrough, writing: Scientists successfully used CRISPR to fix a mutation that causes disease. This is why I wanted to be a geneticist!

The tweet ignited among his followers the same range of responses that are always so keenly tied to the issue of changing human genes, from hope that devastating conditions such as muscular dystrophy will be eradicated, to fear about the unknown consequences of playing God.

Dr. Timothy Caulfield, a Canada Research Chair in Health Law and Policy and professor at the University of Alberta, says the polarized and dramatic response he has seen in recent days reminds him of early reaction to stem-cell science, where, he says, It was either going to be cloned armies, or we were going to eradicate all disease.

In fact, neither has turned out to be the case, and so it may be with gene editing as well.

We need to be cautious not to hype the benefits and be cautious not to hype the ethical concerns, he says. There are real issues on both sides of the debate but lets make sure our discourse is evidence-formed.

He described the new research as a genuinely exciting area, and said the potential of CRISPR which is used not only in human genetics, but also has potentially revolutionary applications for agriculture, animals, plants and food has introduced both exciting possibilities and reasons for deep policy reflection.

Erika Kleiderman, a lawyer and academic whose work focuses on gene-editing technologies, stem-cell research and regenerative medicine at the Centre of Genomics and Policy at McGill University, says the Oregon teams research is exciting because it confirms the ability of CRISPR technology to repair genetic mutations, and establishes the basic safety of the technique in a research context. And while she said people often go straight to thinking about the potential for manipulating genes to create so-called designer babies, a concept that is cool but also quite frightening, the medical implications could be equally staggering, and are far more likely.

For example, something like Huntington disease, she says. Being able to prevent that or treat that one day, in my opinion, would be a fantastic leap for our scientific knowledge and medical advancement. That being said, people will raise the eugenics argument. Is that a possibility? Yes. Are we close to that? I dont think so.

Canada has strict laws around genetic modification and editing, and altering genes in a way that could be passed on to future generations is a criminal offence under the Assisted Human Reproduction Act, punishable with fines up to $500,000 or 10 years in prison.

But as the technology takes a large step forward, Ms. Kleiderman and Dr. Caulfield and are among a group of Canadian scientists and academics calling for less regulation around genetic science and research in Canada, not more.

Both were involved in the creation of an editorial published in the journal Regenerative Medicine in January calling for new consideration of the issues and ethics involved in gene editing, and a revision of Canadian legal policy.

A criminal ban is a suboptimal policy tool for science as it is inflexible, stifles public debate, and hinders responsiveness to the evolving nature of science and societal attitudes, the editorial read. It was signed by seven other experts and ethicists, and came out of a think tank on the future of human gene editing in Canada held at McGill last summer.

Dr. Caulfield says legal prohibition of certain genetic research doesnt make sense when we dont yet know or understand where the science is going, or what the benefits or harms could be. Instead, he says he believes in regulation in problematic areas, while allowing for studies and trials. He says that some of the slippery slope scenarios people fear such as using genetic modification for human enhancement and to achieve superficial traits such as height remain distant possibilities given the complexity of the science.

That is not to say there are not risks or issues to be addressed as the technology continues to evolve. Ms. Kleiderman says that includes consideration of the potential risk to future generations, the safety of the technology and other irrevocable, if unintended, consequences, although she says those risks are not unique to gene modification but true of all technologies.

When it comes to CRISPR, one of the areas it would be most beneficial is with the treatment of prevention of disease which I think most people would be in agreement with, she says. Of course, we need to be mindful of doing not-so-positive things with it, like going down the enhancement route.

She said other potential issues, such as the preservation of human diversity and individuality, the welfare of children born from this technology and the potential for creating new forms of inequality, discrimination or societal conflict, all require significant consideration and research.

There is time. Although the technology is moving quickly, there is still a long way before gene editing is used in clinical human trials. Even after that, Dr. Virani says for the foreseeable future the technology will most likely be used by a small group of people in specific scenarios related to the prevention of serious genetic disease.

Im not saying we shouldnt be concerned about those potential issues, but sometimes we make that leap too quickly, she said. We dont necessarily [think] that the most likely scenario is that couples will use this technology on a very limited basis if they know their child may potentially have a devastating genetic condition. Thats not something that suddenly everyone is going to start to do. I think theres sometimes that leap to, Oh, we can create designer babies, but I think were very much in the lessening-burden-of-disease phase rather than the designer-baby phase, though thats where peoples minds go.

Dr. Virani said one of her own concerns is the possibility of off-target effects, where changing a gene unexpectedly alters something else in the genome. Other concerns are more social reality than science fiction, including that the technology and the ability to prevent disease may only be available to those who can pay for it. Eradicating a horrible disease is one thing. Eradicating it only for families who can afford it is another.

So is it going to look like just the wealthy are going to be able to afford this type of technology? she asks. Thats very problematic in my eyes from an ethics point of view, and thinking about fairness in society. If only poor people get Huntington disease, then the lobby to support Huntington disease research is greatly diminished. Its kind of like a two-fold negative effect.

On Thursday, the American Journal of Human Genetics ran a policy statement signed by 11 organizations from around the world, including the Canadian Association of Genetic Counsellors, urging a cautious but pro-active approach as the science moves forward. The statement includes an agreement that gene editing should not yet be performed in embryos carried on to human pregnancy. (The embryos used in the Oregon research were created only for the research, and were not developed further.) It also outlines a number of criteria that should be met before clinical trials take place, and supports public funding for the research. The U.S. government does not allow federal funding for genetic research on embryos. The Oregon research was funded by the university.

We dont want it to go speeding ahead, said Kelly Ormond, the lead author of the policy statement and a genetics professor at Stanford University in California. We want people to be very transparent about whats happening and we want things to undergo good ethics review, and for society to actually be engaged in these dialogues now while this research is just starting to happen.

She said she believes its important to be pro-active in talking and thinking about the issues related to the technology, and starting a broader conversation of how gene editing should and will be used.

We can all agree that that world [of eugenics and designer babies] doesnt feel very comfortable, and I think most of us dont want to go there, she said. So we need to find ways to prevent that from happening.

Follow Jana G. Pruden on Twitter: @jana_pruden

Read the original:
Modification of genes in human embryos could mark turning point in human evolution - The Globe and Mail